Insulin resistance syndrome (IRS)−related phenotypes, such as hyperinsulinemia, obesity-related traits, impaired glucose tolerance, dyslipidemia, and hypertension, tend to cluster into factors. We attempted to identify loci influencing the factors of IRS-related phenotypes using phenotypic data from 261 nondiabetic subjects distributed across 27 low-income Mexican-American extended families. Principal component factor analyses were performed using eight IRS-related phenotypes: fasting glucose (FG), fasting specific insulin (FSI), BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), HDL cholesterol, ln triglycerides (ln TGs), and leptin (LEP). The factor analysis yielded three factors: factor 1 (BMI, LEP, and FSI), factor 2 (DBP and SBP), and factor 3 (HDL and ln TG). We conducted multipoint variance components linkage analyses on these factors with the program SOLAR using a 10–15 cM map. We found significant evidence for linkage of factor 1 to two regions on chromosome 6 near markers D6S403 (logarithm of odds [LOD] = 4.2) and D6S264 (LOD = 4.9). We also found strong evidence for linkage of factor 3 to a genetic location on chromosome 7 between markers D7S479 and D7S471 (LOD = 3.2). In conclusion, we found substantial evidence for susceptibility loci on chromosomes 6 and 7 that appear to influence the factors representing the IRS-related phenotypes in Mexican-Americans.

The insulin resistance syndrome (IRS) is characterized by a number of related disorders, such as insulin resistance and hyperinsulinemia, hypertension, dyslipidemia, impaired glucose tolerance, and obesity (1,2,3). Several epidemiological studies have shown that these disorders are risk factors for coronary heart disease (1,4,5,6). The IRS has been shown to be a predictor of both type 2 diabetes and coronary heart disease (4,7). It is also found to be a strong correlate of obesity and type 2 diabetes in the general population as well as in the Mexican-American population (8,9,10).

Epidemiological studies have documented that IRS-related phenotypes tend to cluster into factors, although the metabolic and physiological mechanisms responsible for this clustering have not yet been elucidated (11,12,13,14). Edwards et al. (11) were the first to use factor analysis to understand the relations among metabolic risk variables. Since then, several studies attempting to identify the major components or common factors underlying the correlation patterns between these related phenotypes have applied factor analysis using population and family or twin data, with sexes combined or treated separately, to examine the factor clustering of IRS-related risk factors in diabetic and nondiabetic subjects (6,11,12,13,15). The clustering of risk factors in the metabolic syndrome may reflect multiple interrelations among these phenotypes and/or a manifestation of a dominant underlying common factor (15,16). For example, hyperinsulinemia is considered to be a predisposing factor for hypertension and dyslipidemia. Some studies have documented the possible role of insulin resistance in contributing to the clustering of lipid disorders, hypertension, and glucose intolerance (1,2,17,18).

There is some evidence, based mostly on twin studies, that additive genetic effects might influence these factors (12,19,20,21). In addition, insulin resistance is strongly associated with type 2 diabetes, given that ∼45% of first-degree relatives of type 2 diabetic patients are insulin resistant compared with 20% of nondiabetic individuals with no family history of type 2 diabetes (22). Using both population (San Antonio Heart Study; n = 2,626) and family data (San Antonio Family Diabetes Study [SAFADS]; n = 343), we recently showed that the IRS-related phenotypes in nondiabetic individuals clustered into similar factors (23). These factors were strongly determined by additive genetic influences, as suggested by the family data from SAFADS (23).

In this study, we attempted to identify the susceptibility loci that influence the IRS factor−specific scores, which are composite risk factors, using phenotypic and genotypic data from a subset of nondiabetic individuals from Mexican-American families. We 1) identified the IRS factor structures, 2) determined the genetic basis for these factors, and 3) identified the susceptibility loci for the IRS factors by conducting a multipoint variance components linkage analysis using a 10–15 cM map.

### Subjects.

Phenotypic and genotypic data were obtained from individuals distributed across 27 Mexican-American families living in San Antonio, Texas, who were participants in the SAFADS. Probands for the SAFADS study were randomly selected, low-income Mexican-Americans with type 2 diabetes identified in a previous epidemiological survey (8,24). All 1st-, 2nd-, and 3rd-degree relatives of the probands, aged ≥18 years, were considered eligible for the study. The Institutional Review Board of the University of Texas Health Science Center at San Antonio approved all procedures, and all subjects gave written informed consent.

We used phenotypic data from 261 nondiabetic individuals, distributed across the 27 largest pedigrees, for whom genotypic data were also available. Only participants for whom data were available for all the phenotypes were included in the study. We have previously described our genotype data in detail, including the procedures for checking genotypic data for Mendelian discrepancies (25,26). Marker information for discrepant individuals was either corrected or blanked out before conducting the analyses. Although we typed 419 markers for two-point linkage analysis, markers with less than ∼80% of the sample typed were not used unless their absence would result in a gap of 20 cM or more (26). Thus, a subset of 301 highly informative microsatellite markers was selected based on their optimal spacing and informativeness.

### Physical and biochemical measurements.

Blood samples were obtained after a 12-h fast, and various metabolic traits, including glucose, triglyceride (TG), and HDL cholesterol (HDL-C) levels were measured using enzymatic and precipitation procedures, as previously described (8,9). We assessed the extent of measurement error using duplicate measures for a given trait. Accordingly, the technical error of measurement for HDL-C and TG values was 1.1 and 1.2% of the mean, respectively. TG values >800 mg/dl were considered as outliers and were excluded from the analysis. TG values were log transformed (ln TG) because the raw values exhibited high nonnormality. Fasting specific insulin (FSI) concentrations were measured using a monoclonal antibody−based two-site immunoradiometric assay (27). We used the FSI concentration because, unlike conventional fasting immunoreactive insulin, it does not cross-react with insulin precursors. Serum leptin (LEP) was measured by a radioimmunoassay (28). Blood pressure levels, both systolic (SBP) and diastolic (DBP), were measured to the nearest 2 mmHg with a Random-Zero sphygmomanometer (Gelman-Hawksley, Lancing, Sussex, U.K.). Anthropometric traits, including height and weight, were collected using standardized anthropometric protocols (8,9). BMI was calculated as weight (in kilograms) divided by height (in meters) squared.

### Statistical methods.

Principal component factor analysis (PCFA) was performed to extract the underlying factors of IRS-related phenotypes. Before conducting PCFA, trait-specific values that fell beyond 4 SDs from the mean of the trait were considered as outliers and were excluded from the PCFA analysis. As stated above, TG values were log transformed to circumvent the problem of high nonnormality. PCFA is a data-reduction technique that reduces a large number of correlated variables into fewer uncorrelated factors, thereby reducing the problem of correcting for multiple comparisons (29,30). PCFA is a three-step process. The first step involves principal component analysis, which is used to reduce highly correlated original variables to fewer uncorrelated components. These components are linear combinations that account for the maximum amount of total variance in the original variables. The first extracted factor accounts for the largest amount of the variability among the measured variables, whereas subsequent factors explain additional variability in decreasing order. The number of significant components is determined based on eigenvalues, which are the sum of the squared factor loadings (29). These eigenvalues represent the amount of variance attributable to each factor. In the second step, the factors with eigenvalues ≥1.0 (i.e., factor 1, factor 2, and factor 3, with eigenvalues of 2.8, 1.7, and 1.0, respectively) are extracted using a varimax rotation method to produce interpretable factors (29). The third step involves the interpretation of these factors by examining the factor loadings, which are the correlations between each variable and the factor in question. Factor loadings ≥0.40 are generally used to interpret factors and characterize the factor structures (29). All factor analyses were performed using SAS software (31).

Multipoint variance components linkage analyses were performed on the factor scores to identify chromosomal regions containing susceptibility loci for each factor using the variance components approach (32). With this method, the expected genetic covariances between relatives are specified as a function of their identity-by-descent (IBD) relationships at a marker locus that is assumed to be closely linked to a locus influencing the quantitative trait in question. The covariance matrix for a given pedigree is given by the following equation:

${\Omega}{=}{\Pi}{\sigma}^{2}_{q}{+}2{\Phi}{\sigma}^{2}_{g}{+}{I}{\sigma}^{2}_{e}$

where Ω is the covariance matrix for a pedigree; Π is a matrix with elements (πqij) specifying the expected proportion of alleles that individuals i and j share IBD at the specific chromosomal location of the quantitative trait locus, which is estimated using genetic marker data; ς2q is the additive genetic variance attributable to the major locus; Φ is the kinship matrix; ς2g is the variance attributable to residual additive genetic effects; I is an identity matrix; and ς2e is the variance attributable to random environmental effects. Location-specific IBD information for pairs of relatives was obtained by the program SOLAR (32). We conducted multipoint variance components linkage analysis according to the procedures outlined in the computer program SOLAR using a 10- to 15-cM map to localize the loci influencing the uncorrelated factors extracted through PCFA analysis. The coefficients of skewness and kurtosis for each factor (i.e., factor scores) after adjusting for the effects of age and sex terms are as follows: factor 1, skewness = 0.9 and kurtosis = 0.8; factor 2, skewness = 0.4 and kurtosis = 0.6; and factor 3, skewness = 0.4 and kurtosis = 0.0. These factor-specific distributional properties suggest that the factor scores used in this study minimally violated the assumption of normality.

To verify our findings on chromosomes 6 and 7, we used simulations to obtain empirical P values. In the simulation analysis, a fully informative marker that was not linked to the quantitative trait locus influencing a given factor was simulated. For this simulated marker, IBD information was calculated, and linkage analysis was then conducted. We generated 100,000 replicates to determine the empirical P value. This procedure was implemented in the program SOLAR.

The characteristics of the subjects used in the study are presented in Table 1. Correlations among the phenotypes are presented in Table 2. The majority of the correlations among eight phenotypes are significant (P < 0.001), although a few correlations are not. BMI and ln TG showed significant correlations with all the traits, whereas in men LEP showed significant correlations with BMI, FSI, and ln TG, and in women LEP showed significant correlations with all traits except SBP.

The factors and patterns of factor loadings obtained in this study are shown in Table 3. In the factor analysis, three factors were extracted by PCFA. Factor 1 exhibited high and positive correlations with BMI, LEP, and FSI, explaining 35% of the total variance. Factor 2 showed high loadings for only DBP and SBP, and factor 3 showed a high positive association with HDL-C values and a negative association with ln TG values, thus reflecting the inverse relationship between HDL-C and ln TG values. In all, ∼68% of the total variance was cumulatively explained by these three factors (Table 3). Because factor 1 is dominated by large positive correlations for BMI, FSI, and LEP, this factor can be interpreted as an adiposity-insulin factor. Because it is dominated by DBP and SBP, factor 2 is interpreted as a blood pressure factor. In contrast, large positive correlation with HDL-C and large negative correlation with ln TG dominated factor 3; therefore, this factor can be interpreted as a lipid profile factor.

Heritabilities were estimated for all three factors using variance components analysis. After accounting for covariates (i.e., age and sex terms), heritabilities for the three factors ranged from 49 to 58% (Table 4). Heritabilities of all the factors were moderate to high and statistically significant (P < 0.0001) (Table 4). The results of our multipoint linkage analysis for IRS factor susceptibility loci with multipoint peak logarithm of odds (LOD) score ≥1.9 are reported in Table 5.

As shown in Fig. 1, we found significant evidence for linkage of the adiposity-insulin factor (factor 1; LOD score = 4.9, empirical P value = 0.00002) to a genetic location at 208 cM from p-ter on chromosome 6q (near marker D6S264). Marker D6S403 region on chromosome 6q was also found to be strongly linked (LOD = 4.2, empirical P value = 0.00013) with factor 1. We also observed strong evidence for linkage of factor 3, the lipid profile factor, to a genetic location on chromosome 7 between markers D7S479 and D7S471 (LOD = 3.2, empirical P value = 0.00016) (Fig. 2). The blood pressure factor (factor 2) showed suggestive evidence for linkage on chromosome 15 (LOD = 2.0, empirical P value = 0.00181) (Table 5).

Because the IRS consists of several correlated phenotypes, it is important to understand the major component/phenotype or common factors underlying the correlations between these related phenotypes. There is substantial evidence that not only insulin levels and IRS-related phenotypes but also IRS-related factors are under strong genetic influences (10,20,23,32,33,34,35). It should be noted that environmental determinants influence these factor structures as well. Results from some studies involving the Mexican-American population have indicated either directly or indirectly that the IRS-related phenotypes are influenced by a common set of genes (i.e., pleiotropy) (9,10,35). Recently, Duggirala et al. (23) found evidence for genetic influences on factor structures underlying the IRS in nondiabetic Mexican-American family members. We therefore conducted variance component linkage analyses to identify the specific chromosomal regions across the genome that harbor susceptibility loci for these IRS factor structures in Mexican-Americans.

In this study, we performed PCFA to extract factors on IRS-related phenotypes, including fasting glucose, FSI, BMI, SBP, DBP, HDL, ln TG, and LEP. We obtained three factors that represented an adiposity-insulin factor (BMI, FSI, and LEP), a blood pressure factor (DBP and SBP), and a lipid profile factor (HDL and ln TG). These findings were consistent with previous studies that have used factor analysis to reduce the number of variables to two to four uncorrelated factors in nondiabetic subjects (6,11,13,14,15,16,36). For example, Gray et al. (14) found three factors among nondiabetic adult male and female Native American Indians in the Strong Heart Study—the glucose/obesity factor (BMI, glucose, and insulin), the blood pressure factor (SBP and DBP), and the dyslipidemia factor (TG and HDL)—which are identical to the factors derived in the present study.

Our factor analyses results are consistent with the findings of the majority of studies that insulin variables load on the same factor as glucose and obesity variables, and sometimes lipid variables, whereas blood pressure variables load on a separate factor (17,18,37). On the other hand, our study showed that FSI, a surrogate for insulin resistance, failed to load on all the factors, thereby implying that insulin resistance may not have a unifying effect on the IRS (38). Also, our data support the observation of Hodge et al. (39) who, using data from a Mauritian population, concluded that more than one mechanism might account for the observed clustering of IRS-related variables. Caution is necessary, however, in making direct comparisons, as the components of each factor, number of factors, type of variables, and specific ethnic groups examined vary from study to study. Aside from these issues, in this study, the composite factors of the IRS-related phenotypes were found to be under substantial additive genetic influences. The factor heritabilities are comparable to heritabilities of the IRS factors previously estimated in a sample of Caucasian women twins (12).

The region near marker D6S264 on chromosome 6q also appears to be the same region that was previously found to have significant common genetic effects (i.e., pleiotropy) on various IRS-related phenotypes. Also, both marker regions of interest in this study (i.e., D6S403 and D6S264) have been shown to contain susceptibility loci for the IRS-related phenotypes in various populations. Thus, as discussed above, several methods, including multivariate linkage analysis and principal components-based linkage approaches, have been used to examine whether correlated phenotypes are under shared genetic influences (30,35). One approach, used in this study, is to subject a given set of correlated phenotypes to principal components factor analysis to obtain a few principal factors, and to conduct multipoint linkage analysis using those factors. This strategy reduces the problems associated with multiple comparisons (30,32) or the issues related to degrees of freedom in multivariate analysis. For example, factor 1 in this study, as a single composite phenotype, represents information related to three constituents of the IRS: FSI, BMI, and LEP.

The second major region on chromosome 7 between markers D7S479 (7q21.3) and D7S471 (7q31.1) with strongest evidence for linkage of our lipid profile factor (factor 3; LOD = 3.2), has also reported to be linked with type 2 diabetes or its related quantitative traits in Pima Indians (41). In addition, these results correspond well with the findings of Imperatore et al. (42), who reported evidence of linkage for lipid factor in Pima Indians on chromosome 7 at q22.2. In another study (26), based on univariate linkage findings, we found that TG concentrations were suggestively linked (LOD = 2.1) to a genetic location centromeric to marker D7S479, and that HDL concentrations were also linked to a location near marker D7S479 (LOD = 1.7). Although the LOD curves peaked at different locations for these phenotypes, the trait-specific linkage curves overlapped, which may indicate a locus influencing both phenotypes. In fact, the genetic location found to be strongly linked (LOD = 3.2) to the lipid construct (factor 3) overlaps very well with our earlier HDL linkage finding on chromosome 7q.

The genetic regions of interest on chromosome 6q contain several known candidate genes for the IRS. The genetic location near marker D6S403 is very close to the plasma cell membrane glycoprotein PC-1 (6q22-q23), a potential candidate gene for insulin resistance (43). The second linked region near D6S264 also appears to harbor candidate genes for IRS, such as IGF2R (6q26) (44) and ACAT2 (6q25.3-q26) (44). The chromosomal region of interest near D7S479 (7q21.3) contains several potential candidate genes for the IRS, such as paraoxonase and plasminogen activator inhibitor. Another candidate gene for the IRS, which is not far from our chromosomal region of interest on chromosome 7, is the collagen and thrombospondin receptor CD36 (44), which is localized to band 7q11.2 (45).

To our knowledge, only one other study has attempted to identify loci affecting the IRS factors using data from the Pima Indian population (42). In this study, strong evidence was found for a locus near marker D1S2141 on chromosome 1 linked to an insulin-glucose factor, and another locus on chromosome 7 was found to influence one or more components of the metabolic syndrome, including the lipid factor. We failed to replicate the finding involving the marker region near D1S2141. However, as shown in Table 5, we found evidence for one locus near marker D1S305 (LOD = 2.6) influencing the adiposity-insulin factor and another locus near marker D1S431 (LOD = 1.9) influencing the lipid factor. These markers are about 29 cM apart on our map. The marker D1S305 region strongly overlaps with the chromosomal region (i.e., a genetic location between markers D1S305 and D1S1600) reported to be linked to familial partial lipodystrophy (Dunnigan variety), which is characterized by conditions such as insulin resistance, diabetes, and dyslipidemia (46). Also, our regions near markers D1S305 and D1S431 overlap with the genetic location(s) on chromosome 1q found to be linked with diabetes in the Pima population (47). The marker D1S431 region also overlaps with the chromosomal region reported to be linked with diabetes in a Caucasian population (34).

Several of the chromosomal regions found to be suggestively linked to the IRS factors in this study (Table 5) have been shown to be linked to one or more phenotypes related to the IRS in various populations. For example, suggestive evidence for linkage of diabetes to the marker D9S301 was found using family data from the Botnia region in Finland (48). In Pima Indians, some evidence for linkage of fasting insulin was reported to a genetic location close to the D9S301 marker region (44). The adiposity-insulin factor was found to be linked to a location near marker D2S141, which overlaps with a region on chromosome 2q that shows some evidence of linkage to diabetes-related phenotypes (35,49). Several studies have reported linkage of diabetes- or obesity-related phenotypes to different, but overlapping, genetic regions on chromosome 20q (35,50), which correspond to the genetic region near marker D20S170 found to be suggestively linked to adiposity-insulin factor in this study.

In conclusion, we determined factor structures that underlie the IRS-related phenotypes in a Mexican-American population. We also found that these factors of the IRS are substantially influenced by additive genetic factors. Subsequently, by the use of a multipoint variance components technique, we identified two major loci on chromosome 6q that influence the adiposity-insulin factor, and another locus on chromosome 7q that significantly influences the lipid factor. In addition, several other chromosomal regions, identified earlier as influencing one or more of the constituents of the IRS, have also been found to influence the various factor structures examined in this study. These results provide strong evidence for major locus effects on the phenotypic variance of the factor structures that underlie the IRS in Mexican-Americans.

FIG. 1.

Multipoint linkage profile of factor 1 on chromosome 6.

FIG. 1.

Multipoint linkage profile of factor 1 on chromosome 6.

Close modal
FIG. 2.

Multipoint linkage profile of factor 3 on chromosome 7.

FIG. 2.

Multipoint linkage profile of factor 3 on chromosome 7.

Close modal
TABLE 1

Characteristics of 261 nondiabetic Mexican-American Individuals

n (M/F)108/153
Age (years) 38.5 ± 15.6
Fasting glucose (mg/dl) 88.6 ± 10.8
Fasting specific insulin (pmol/l) 125.5 ± 80.4
BMI (kg/m229.1 ± 6.3
Systolic blood pressure (mmHg) 118.4 ± 16.0
Diastolic blood pressure (mmHg) 70.9 ± 10.0
HDL cholesterol (mg/dl) 37.7 ± 9.7
ln triglycerides 4.9 ± 0.6
Leptin (ng/ml) 22.1 ± 17.3
n (M/F)108/153
Age (years) 38.5 ± 15.6
Fasting glucose (mg/dl) 88.6 ± 10.8
Fasting specific insulin (pmol/l) 125.5 ± 80.4
BMI (kg/m229.1 ± 6.3
Systolic blood pressure (mmHg) 118.4 ± 16.0
Diastolic blood pressure (mmHg) 70.9 ± 10.0
HDL cholesterol (mg/dl) 37.7 ± 9.7
ln triglycerides 4.9 ± 0.6
Leptin (ng/ml) 22.1 ± 17.3

Data are n or means ± SD.

TABLE 2

Pearson product moment correlation coefficients of IRS-related phenotypes

BMIDBPSBPFGFSIHDLln TG
BMI — — — — — — —
DBP 0.21 — — — — — —
SBP 0.12 0.52 — — — — —
FG 0.26 0.10* 0.25 — — — —
FSI 0.63 0.15 0.05* 0.25 — — —
HDL −0.37 −0.17 −0.07* −0.13 −0.26 — —
ln TG 0.32 0.29 0.34 0.28 0.28 −0.40 —
Leptin
Men (n = 108) 0.64 −0.05* 0.01* 0.09* 0.52 −0.17* 0.23
Women (n = 153) 0.76 0.30 0.13* 0.29 0.66 −0.21 0.26
Men and women (n = 261) 0.62 −0.01* −0.14 0.08* 0.52 −0.05* 0.04*
BMIDBPSBPFGFSIHDLln TG
BMI — — — — — — —
DBP 0.21 — — — — — —
SBP 0.12 0.52 — — — — —
FG 0.26 0.10* 0.25 — — — —
FSI 0.63 0.15 0.05* 0.25 — — —
HDL −0.37 −0.17 −0.07* −0.13 −0.26 — —
ln TG 0.32 0.29 0.34 0.28 0.28 −0.40 —
Leptin
Men (n = 108) 0.64 −0.05* 0.01* 0.09* 0.52 −0.17* 0.23
Women (n = 153) 0.76 0.30 0.13* 0.29 0.66 −0.21 0.26
Men and women (n = 261) 0.62 −0.01* −0.14 0.08* 0.52 −0.05* 0.04*
*

Not significant.

TABLE 3

Factor 1Factor 2Factor 3
BMI 0.83 0.17 −0.30
DBP 0.07 0.79 −0.08
SBP −0.08 0.88 −0.06
FG 0.26 0.38 −0.22
FSI 0.80 0.11 −0.22
HDL −0.12 0.02 0.89
ln TG 0.12 0.39 −0.69
Leptin 0.88 −0.11 0.13
Eigenvalue 2.8 1.7 1.0
Total variance (%) 35 21 12
Cumulative variance (%) 35 56 68
Factor 1Factor 2Factor 3
BMI 0.83 0.17 −0.30
DBP 0.07 0.79 −0.08
SBP −0.08 0.88 −0.06
FG 0.26 0.38 −0.22
FSI 0.80 0.11 −0.22
HDL −0.12 0.02 0.89
ln TG 0.12 0.39 −0.69
Leptin 0.88 −0.11 0.13
Eigenvalue 2.8 1.7 1.0
Total variance (%) 35 21 12
Cumulative variance (%) 35 56 68
TABLE 4

Constructs and heritabilities of factors of IRS-related phenotypes

FactorConstructsHeritability*
Blood pressure factor 0.58 ± 0.16
Lipid profile factor 0.49 ± 0.13
FactorConstructsHeritability*
Blood pressure factor 0.58 ± 0.16
Lipid profile factor 0.49 ± 0.13

Data are heritability ± SE. All heritabilities are significant at P < 0.0001.

TABLE 5

Factors of IRS-related phenotypes and the chromosomal regions to which they were linked in a genome scan with a multipoint LOD score ≥1.9

FactorChromosomeLocation (cM)Marker regionLOD
188 D1S305 2.6
162 D2S141 2.3
208 D6S264 4.9
149 D6S403 4.2
67 D9S301 2.8
12 119 D12S1052-D12S1064 2.2
19 88 D19S246 2.6
20 76 D20S170 2.3
15 61 D15S659-D15S103 2.0
217 D1S431 1.9
130 D7S479-D7S471 3.2
178 D7S1824-D7S688 1.9
28 D9S925-D9S741 2.0
FactorChromosomeLocation (cM)Marker regionLOD
188 D1S305 2.6
162 D2S141 2.3
208 D6S264 4.9
149 D6S403 4.2
67 D9S301 2.8
12 119 D12S1052-D12S1064 2.2
19 88 D19S246 2.6
20 76 D20S170 2.3
15 61 D15S659-D15S103 2.0
217 D1S431 1.9
130 D7S479-D7S471 3.2
178 D7S1824-D7S688 1.9
28 D9S925-D9S741 2.0

Location is distance from p-ter.

This research was supported by grants from the National Institutes of Health (RO1-DK-42273, RO1-DK-47482, RO1-DK-53889, and MH-59490).

We thank the subjects—the participants of SAFADS—for their cooperation and participation. We also thank Prof. C. N. Hales, University of Cambridge, Cambridge, U.K. for measuring the specific insulin levels for this study.

1.
Reaven GM: Role of insulin resistance in human disease.
Diabetes
37
:
1595
–1607,
1988
2.
DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
Diabetes Care
14
:
173
–194,
1991
3.
Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin resistance syndrome (syndrome X).
Diabetes
41
:
715
–722,
1992
4.
Stern MP: Diabetes and cardiovascular disease: the “common soil” hypothesis.
Diabetes
44
:
369
–374,
1995
5.
Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp RM, Comuzzie AG, Vandeberg JL, Stern MP, MacCluer JW: Genetic and environmental contributions to cardiovascular risk factors in Mexican-Americans.
Circulation
94
:
2159
–2170,
1996
6.
Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J: Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.
Circulation
100
:
123
–128,
1999
7.
Reaven GM, Laws A: Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease.
Diabetologia
37
:
948
–952,
1994
8.
Stern MP, Morales PA, Valdez RA, Monterrosa A, Haffner SM, Mitchell BD, Hazuda HP: Predicting diabetes: moving beyond impaired glucose tolerance.
Diabetes
42
:
706
–714,
1993
9.
Duggirala R, Stern MP, Mitchell BD, Reinhart LJ, Shipman PA, Uresandi OC, Chung WK, Leibel RL, Hales CN, O’Connell P, Blangero J: Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7.
Am J Hum Genet
59
:
694
–703,
1996
10.
Mitchell BD, Kammerer CM, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD, Haffner SM, Stern MP, MacCluer JW: Genetic analysis of the IRS: pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures.
Arterioscler Thromb Vasc Biol
16
:
281
–288,
1996
11.
Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV: Multivariate analysis of the insulin resistance syndrome in women.
Arterioscler Thromb
14
:
1940
–1945,
1994
12.
Edwards KL, Newman B, Mayer E, Selby JV, Krauss RM, Austin MA: Heritability of factors of the insulin resistance syndrome in women twins.
Genet Epidemiol
14
:
241
–253,
1997
13.
Meigs JB, D’Agostino RB Sr, Wilson PWF, Cupples LA, Nathan DM, Singer DE: Risk variable clustering in the insulin resistance syndrome: the Framingham offspring study.
Diabetes
46
:
1594
–1600,
1997
14.
Gray RS, Fabistz RR, Cowan LD, Lee ET, Howard BV, Savage PJ: Risk factor clustering in the insulin resistance syndrome: the Strong Heart Study.
Am J Epidemiol
148
:
869
–878,
1998
15.
Edwards KL, Burchfiel CM, Sharp DS, Curb JD, Rodriquez BL, Fujimoto WY, LaCroix AZ, Vitiello MV, Austin MA: Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men.
Am J Epidemiol
147
:
441
–447,
1998
16.
Chen W, Srinivasan SR, Elkasabany A, Berenson GS: Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents, and young adults.
Am J Epidemiol
150
:
667
–674,
1999
17.
Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G: Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships?
Arteriosclerosis
7
:
197
–202,
1987
18.
Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome.
Diabetologia
34
:
416
–422,
1991
19.
Carmelli D, Cardon LR, Fabsitz R: Clustering of hypertension, diabetes, and obesity in adult male twins. Same genes or same environments?
Am J Hum Genet
55
:
566
–573,
1994
20.
Mayer E, Newman B, Austin MA, Zhang D, Quesenberry CP, Edwards K, Selby JV: Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins.
Am J Epidemiol
143
:
323
–332,
1996
21.
Hong Y, Pedersen NL, Brismar K, de Faire U: Genetic and environmental architecture of the features of the insulin resistance syndrome.
Am J Hum Genet
60
:
143
–152,
1997
22.
Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnstrom B-O, Forsen B, Isomaa B, Snickars B, Taskinen M-R: Metabolic consequences of a family history of NIDDM (the Botnia Study).
Diabetes
45
:
1585
–1593,
1996
23.
Duggirala R, Williams K, Arya R, Blangero J, Stern MP: Genetics of the factors underlying the insulin resistance syndrome in nondiabetic Mexican-Americans.
Am J Hum Biol
12
:
274
,
2000
24.
Stern MP, Patterson JK, Haffner SM, Hazuda HP, Mitchell BD: Lack of awareness and treatment of hyperlipidemia in type 2 diabetes in a community survey.
JAMA
262
:
360
–364,
1989
25.
Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O’Connell P, Stern MP: Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican-Americans.
Am J Hum Genet
64
:
1127
–1140,
1999
26.
Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O’Connell P, Stern MP: A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican-Americans.
Am J Hum Genet
66
:
1237
–1244,
2000
27.
Sobey WJ, Beer SF, Carrington CA, Clark PMS, Frank BH, Gary IP, Luzio SD, Owens DR, Schneider AE, Siddle K, Temple RC, Hales CN: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins.
Biochem J
260
:
535
–541,
1989
28.
Ma Z, Gingerich RL. Santiago JV, Klein S, Smith HC, Landt M: Radioimmunoassay of leptin in human plasma.
Clin Chem
42
:
942
–946,
1996
29.
Stevens J:
Applied Multivariate Statistics for the Social Sciences
. Mahwah, NJ, Lawrence Erlbaum Associates,
1996
, p.
362
–392
30.
Ott J, Rabinowitz D: A principal-components approach based on heritability for combining phenotype information.
Hum Hered
49
:
106
–111,
1999
31.
SAS Institute:
SAS/STAT User’s Guide, Version 6
. 4th ed. Carey, NC, SAS Institute,
1990
32.
Almasy L, Blangero J: Multipoint quantitative trait linkage analysis in general pedigrees.
Am J Hum Genet
62
:
1198
–1211,
1998
33.
Stern MP, Mitchell BD: Genetics of insulin resistance. In
Insulin Resistance: The Metabolic Syndrome X
. Reaven G, Laws A, Eds. Totowa, NJ, Humana Press,
1999
, p.
3
–18
34.
Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ: A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians.
Diabetes
48
:
1175
–1182,
1999
35.
Duggirala R, Blangero J, Almasy L, Arya R, Dyer TD, Williams K, Leach RJ, O’Connell P, Stern MP: A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in non-diabetic Mexican-Americans.
Am J Hum Genet
68
:
1149
–1164,
2001
36.
Hanson RL, Imperatore G: Factor analysis of variables related to the metabolic syndrome in Pima Indians.
Diabetes Suppl
48
:
A167
,
1999
37.
Miegs JB: Invited commentary. Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors.
Am J Epidemiol
152
:
908
–911,
2000
38.
Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ: Does insulin resistance unite the separate components of the insulin resistance syndrome?
Arterioscler Thromb Vasc Biol
17
:
2413
–2417,
1997
39.
Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KGM: Leptin and other components of the metabolic syndrome in Mauritius: a factor analysis.
Int J Obes Relat Metab Disord
25
:
126
–131,
2001
40.
Stern MP, Duggirala R, Mitchell BD, Reinhart LJ, Shivakumar S, Shipman PA, Uresandi OC, Benavides E, Blangero J, O’Connell P: Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican-Americans.
Genome Res
6
:
724
–734,
1996
41.
Hanson RL, Knowler WC, the Pima Diabetes Genes Group: Linkage analyses of insulin levels in a genome-wide scan in nondiabetic Pima Indians (Abstract).
Diabetes
47 (Suppl. 1)
:
A170
,
1998
42.
Imperatore G, Knowler WC, Kobes S, Bennett PH, Hanson RL: Genome-wide linkage analysis of factors characterizing the metabolic syndrome among Pima Indians (Abstract).
Diabetes
48 (Suppl. 1)
:
A182
,
1999
43.
Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID: Membrane glycoprotein PC-1 and insulin resistance in non-insulin dependent diabetes.
Nature
373
:
448
–451,
1995
44.
Online Mendelian Inheritance in Man (OMIM); McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD),
2000
. Available from http://www.ncbi.nlm.nih.gov/omim
45.
Fernandez-Ruiz E, Armesilla AL, Sanchez-Madrid F, Vega MA: Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7q11.2.
Genomics
17
:
759
–761,
1993
46.
Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A: Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22.
Nat Genet
18
:
292
–295,
1998
47.
Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, Knowler WC: An autosomal genomic scan for loci linked to type 2 diabetes mellitus and body mass index in Pima Indians.
Am J Hum Genet
63
:
1130
–1138,
1998
48.
Lindgren CM, Mahtani MM, Widen E, McCarthy MI, Kirby A, Daly M, Lehto M, Kanninen T, Almgren P, Tuomi T, Groop LC, Lander ES: A genome-wide scan for susceptibility loci to type 2 diabetes in the Botnia region in Finland. Paper presented at: 2nd Research Symposium on the Genetics of Diabetes, sponsored by the American Diabetes Association, San Jose, CA,
17
–19 October
1999
49.
Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P: Genomewide search for type 2 diabetes−susceptibility genes in French whites: evidence for a novel susceptibility locus for early onset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21–q24.
Am J Hum Genet
67
:
1470
–1480,
2000
50.
Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR, Langefeld CD, Balow J Jr, Ally DS, Kohtamaki K, Chines P, Birznieks G, Kaleta HS, Musick A, Te C, Tannenbaum J, Eldridge W, Shapiro S, Martin C, Witt A, So A, Chang J, Shurtleff B, Porter R, Kudelko K, Unni A, Segal L, Sharaf R, Blaschak-Harvan J, Eriksson J, Tenkula T, Vidgren G, Ehnholm C, Tuomilehto-Wolf E, Hagopian W, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M: Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs.
Proc Natl Acad Sci U S A
96
:
2198
–2203,
1999

Address correspondence and reprint requests to Dr. Rector Arya, Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900. E-mail: arya@uthscsa.edu.

Received for publication 31 July 2001 and accepted in revised form 4 December 2001.

DBP, diastolic blood pressure; FG, fasting glucose; FSI, fasting specific insulin; HDL-C, HDL cholesterol; IBD, identity by descent; IRS, insulin-resistance syndrome; LEP, leptin; ln TG, log-transformed TG values; LOD, logarithm of odds; PCFA, principal component factor analysis; SAFADS, San Antonio Family Diabetes Study; SBP, systolic blood pressure; TG, triglyceride.